NSRX · Company research

Nasus Pharma Ltd. (NSRX): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

15records availableHealthcare

Stock News & Events data

Database-backed records only

15 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
At the October 8 meeting, Nasus Pharma (NSRX) shareholders approved all agenda items except one. - Stock TitanAt the October 8 meeting, Nasus Pharma (NSRX) shareholders approved all agenda items except one. Stock TitanView source ↗Stock TitanOct 8, 2026neutral00.6
Nasus (NSRX) Charges Higher by +2.75%, Clearing $4.12 2026-10-04 - Long Term Entry Picks - https://www.siam.in/Nasus (NSRX) Charges Higher by +2.75%, Clearing $4.12 2026-10-04 - Long Term Entry Picks https://www.siam.in/View source ↗https://www.siam.in/Oct 4, 2026neutral00.6
Nasus (NSRX) Charges Higher by +2.75%, Clearing $4.12 2026-10-04 - Ichimoku TK Cross - https://www.dars.gov.et/Nasus (NSRX) Charges Higher by +2.75%, Clearing $4.12 2026-10-04 - Ichimoku TK Cross https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Oct 4, 2026neutral00.6
Nasus Pharma (NSRX) Shares Gain 3.78% to $3.57, Approaching Key Resistance - Bollinger Expansion - dars.gov.etNasus Pharma (NSRX) Shares Gain 3.78% to $3.57, Approaching Key Resistance - Bollinger Expansion dars.gov.etView source ↗dars.gov.etSep 22, 2026neutral00.6
New Nasus Pharma (NYSE: NSRX) share plan could dilute holders while funding anaphylaxis drug trials - Stock TitanNew Nasus Pharma (NYSE: NSRX) share plan could dilute holders while funding anaphylaxis drug trials Stock TitanView source ↗Stock TitanSep 18, 2026neutral00.6
NSRX: Nasus Pharma Ltd. Latest Stock Price, Analysis, News and Trading Ideas - StocktwitsNSRX: Nasus Pharma Ltd. Latest Stock Price, Analysis, News and Trading Ideas StocktwitsView source ↗StocktwitsSep 14, 2026neutral00.6
Nasus Pharma Ltd SEC Filing (Sep 14, 2026) - Stock TitanNasus Pharma Ltd SEC Filing (Sep 14, 2026) Stock TitanView source ↗Stock TitanSep 14, 2026neutral00.6
Nasus Pharma Sets October 8, 2026 Shareholder Meeting to Vote on Governance, Executive Pay and Option Pool - The Globe and MailNasus Pharma Sets October 8, 2026 Shareholder Meeting to Vote on Governance, Executive Pay and Option Pool The Globe and MailView source ↗The Globe and MailSep 5, 2026neutral00.6
NSRX Forecast — Price Target — Prediction for 2027 - TradingViewNSRX Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 26, 2026neutral00.6
Insider Purchase: Chief Executive Officer of $NSRX Buys 2,900 Shares | NSRX Stock News - Quiver QuantitativeInsider Purchase: Chief Executive Officer of $NSRX Buys 2,900 Shares | NSRX Stock News Quiver QuantitativeView source ↗Quiver QuantitativeApr 23, 2026neutral00.6
$NSRX stock is up 22% today. Here's what we see in our data. - Quiver Quantitative$NSRX stock is up 22% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeApr 22, 2026neutral00.6
Nasus Pharma (NSRX) Stock Forecast and Price Target 2026 - MarketBeatNasus Pharma (NSRX) Stock Forecast and Price Target 2026 MarketBeatView source ↗MarketBeatMar 26, 2026neutral00.6
Nasus Pharma: Recent Market Movements and Stock Analysis - Timothy SykesNasus Pharma: Recent Market Movements and Stock Analysis Timothy SykesView source ↗Timothy SykesMar 16, 2026neutral00.6
Nasus Pharma (NSRX) Stock Price, News & Analysis - MarketBeatNasus Pharma (NSRX) Stock Price, News & Analysis MarketBeatView source ↗MarketBeatJan 16, 2026neutral00.6
Nasus Pharma Ltd. (NSRX) stock price, news, quote and history - Yahoo Finance UKNasus Pharma Ltd. (NSRX) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKAug 12, 2025neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.